237 results
Page 5 of 12
424B5
upc9t4q53bzey4w wd
13 Nov 20
Prospectus supplement for primary offering
4:31pm
6-K
EX-10.1
vaxela6
25 Sep 20
Current report (foreign)
4:33pm
424B5
1jid2b 71f8nhi6g3
25 Sep 20
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
ba1bt5d4t95gq
19 Aug 20
2020 Annual General Meeting of Shareholders
4:34pm
POS AM
v13nh7psdprj8at0n
10 Aug 20
Prospectus update (post-effective amendment)
12:00am
6-K
EX-99
022 2gc5ol
6 Aug 20
BioLineRx Reports Second Quarter 2020 Financial Results
7:47am
6-K
EX-99
x8qm0zat 2zs
6 Aug 20
BioLineRx Reports Second Quarter 2020 Financial Results
7:47am
424B3
8mw82gqrx 5umu
2 Jul 20
Prospectus supplement
4:28pm
F-1
rijur9nxdpa c094s
26 Jun 20
Registration statement (foreign)
4:30pm
424B5
nv4mpp0ubvs0mgkjg
3 Jun 20
Prospectus supplement for primary offering
8:33am
6-K
EX-99
9exjyv
3 Jun 20
Current report (foreign)
8:30am
424B5
9mhk80v s7
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-99
u6qd2ukvz6nki7o6pn8
28 May 20
Current report (foreign)
11:56am
6-K
EX-99
pkmbq
20 May 20
BioLineRx Reports First Quarter 2020 Financial Results
7:00am
6-K
EX-99
kvbo2b3rb9t
20 May 20
BioLineRx Reports First Quarter 2020 Financial Results
7:00am
6-K
EX-99
hlbfspfg3pvt4027vw
12 Mar 20
BioLineRx Reports Year-End 2019 Financial Results
7:00am
6-K
EX-99
hi4ic
30 Jan 20
Extraordinary General Meeting of Shareholders
7:00am
6-K
EX-99
tl7xj92i exsl
13 Dec 19
BioLineRx Announces Updated Phase 2a Data from Triple
7:00am